Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + Norcisapride
|
DCB03DI
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Acetazolamide + Norcisapride
|
DC9P6XB
|
Acetazolamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Atenolol + Norcisapride
|
DC31IBR
|
Atenolol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BIO-300 + Norcisapride
|
DCETY41
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bortezomib + Norcisapride
|
DC1ZZ4Z
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Brincidofovir + Norcisapride
|
DCAJGMG
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Dantrolene + Norcisapride
|
DC4GGA2
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Docetaxel + Norcisapride
|
DCX74JO
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Doxorubicin + Norcisapride
|
DCEFNZE
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Furazolidone + Norcisapride
|
DCWDNJ1
|
Furazolidone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Imatinib + Norcisapride
|
DCO9PLT
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Levamisole + Norcisapride
|
DC4CIFI
|
Levamisole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Mefloquine + Norcisapride
|
DCI2KTB
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Metaxalone + Norcisapride
|
DCF1MYZ
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Miglustat + Norcisapride
|
DCZ2HJA
|
Miglustat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Primidone
|
DC59HZV
|
Primidone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Epinephrine
|
DCH38W2
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Sivelestat
|
DCCMVWI
|
Sivelestat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Fomepizole
|
DCMOD0E
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Everolimus
|
DCRHI0L
|
Everolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Metyrosine
|
DCSNANW
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Terameprocol
|
DCXU3Y6
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Chlorzoxazone
|
DCQ6DS8
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Pazopanib
|
DCCB1UC
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Pentamidine
|
DCQEZ6C
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Tolazoline
|
DC4BSRG
|
Tolazoline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Oseltamivir
|
DCMRC4P
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Diazoxide
|
DCZT4EC
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Abacavir
|
DCON96V
|
Abacavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Darunavir
|
DCK01FV
|
Darunavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Moricizine
|
DC7B5NZ
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Artemisinin
|
DC2NTG3
|
Artemisinin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Dopamine
|
DCA31N8
|
Dopamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Trimethobenzamide
|
DCL0MKW
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Maprotiline
|
DCK6L4O
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Oxyphenbutazone
|
DC4ZEC8
|
Oxyphenbutazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Leflunomide
|
DC19D2C
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Bumetanide
|
DCJO6PI
|
Bumetanide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Pomalidomide
|
DCCY9G1
|
Pomalidomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Endoxifen
|
DCR4TV4
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Mycophenolic acid
|
DCEIWEF
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Vorinostat
|
DC2N825
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Cevimeline
|
DCD0KUC
|
Cevimeline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Cerivastatin
|
DCFSPEO
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Busulfan
|
DCIF4WD
|
Busulfan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Atovaquone
|
DCWOJV5
|
Atovaquone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Norcisapride + Azatadine
|
DCCWIZG
|
Azatadine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Olanzapine + Norcisapride
|
DCI7NF8
|
Olanzapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Olmesartan medoxomil + Norcisapride
|
DCFFUMN
|
Olmesartan medoxomil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Phenprocoumon + Norcisapride
|
DCXDGAM
|
Phenprocoumon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Phensuximide + Norcisapride
|
DC19MI1
|
Phensuximide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Pramipexole + Norcisapride
|
DC3IXEN
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Sulfinpyrazone + Norcisapride
|
DCR9OXX
|
Sulfinpyrazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|